2015

20/12/2015

December Newsletter 2015

30/11/2015

Proteomics International Presents PromarkerD at IDF 2015 – Vancouver World Diabetes Congress

20/11/2015

Shareholder Presentation – Annual General Meeting

18/11/2015

Proteomics International receives R&D Tax Incentive Find out more →

09/11/2015

Proteomics International featured in AusIndustry Business News Monthly Innovative diabetic diagnosis recognised

03/11/2015

Managing director, Dr Richard Lipscombe Presents at the Australasian Life Science and Healthcare Showcase 2015 in Seoul

30/10/2015

Proteomics International Invited to Attend the 6th China International Medical Expo

27/10/2015

US Patent granted for Predictive and Diagnostic Test for Diabetic Kidney Disease Find out more →

26/10/2015

Proteomics Technical Presentation Find out more →

26/10/2015

Translating biomarker discovery into a diagnostic test for diabetic kidney disease Find out more →

25/10/2015

Managing director, Dr Richard Lipscombe Presents at the 11th Australian Peptide Conference 2015

25/10/2015

11th Australian Peptide Conference

19/10/2015

Proteomics International wins WA Industry and Export Award Find out more →

09/10/2015

The West Australian Proteomics International is nominated as a finalist in the export category of West Australia’s Industry and Export Awards.

02/09/2015

Investor Presentation – AusBiotech

01/09/2015

Winter Newsletter 2015

19/08/2015

Investor Presentation – Canary Networks

09/06/2015

Ground-breaking Predictive Test for Diagnosis of Diabetic Kidney Disease Find out more →

01/06/2015

Investor Presentation – June 2015

19/05/2015

Global Head of Business Development appointed Find out more →

28/04/2015

Proteomics International secures significant biosimilars contract Find out more →

23/04/2015

Proteomics International secures major contract with The a2 Milk Company Find out more →

16/04/2015

Proteomics International goes public Find out more →

16/04/2015

Proteomics International lists on ASX Find out more →

02/04/2015

Proteomics International successfully closes IPO Find out more →

03/03/2015

The Australian The Human Genome Project represents the single largest undertaking in the history of biological science. Providing investors with cutting-edge exposure to this emerging field [proteomics] is the coming listing of PILL.

16/02/2015

Proteomics International to commercialise DKD test in China Find out more →

04/02/2015

Interview with our Managing Director Wholesale Investor interviews PILL’s Richard Lipscombe on the company’s past and future.

01/02/2015

Summer Newsletter 2015

25/01/2015

BioSpectrum Asia Trends & Responses 2015: Proteomic Laboratories

09/01/2015

Supplementary Prospectus issued Find out more →